Vertex to Present at the Bank of America Securities 2023 Health Care Conference on May 9
April 25 2023 - 08:01AM
Business Wire
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today
announced that management will present at the Bank of America
Securities 2023 Health Care Conference on Tuesday, May 9, 2023 at
9:20 a.m. PT/12:20 p.m. ET.
A live webcast of management's remarks will be available through
the Vertex website, www.vrtx.com in the "Investors" section under
the "News and Events" page. A replay of the conference webcast will
be archived on the company's website.
About Vertex Vertex is a global biotechnology company that
invests in scientific innovation to create transformative medicines
for people with serious diseases. The company has multiple approved
medicines that treat the underlying cause of cystic fibrosis (CF) —
a rare, life-threatening genetic disease — and has several ongoing
clinical and research programs in CF. Beyond CF, Vertex has a
robust clinical pipeline of investigational small molecule, mRNA,
cell and genetic therapies (including gene editing) in other
serious diseases where it has deep insight into causal human
biology, including sickle cell disease, beta thalassemia,
APOL1-mediated kidney disease, acute and neuropathic pain, type 1
diabetes and alpha-1 antitrypsin deficiency.
Founded in 1989 in Cambridge, Mass., Vertex's global
headquarters is now located in Boston's Innovation District and its
international headquarters is in London. Additionally, the company
has research and development sites and commercial offices in North
America, Europe, Australia and Latin America. Vertex is
consistently recognized as one of the industry's top places to
work, including 13 consecutive years on Science magazine's Top
Employers list and one of Fortune’s 100 Best Companies to Work For.
For company updates and to learn more about Vertex's history of
innovation, visit www.vrtx.com or follow us on Facebook, Twitter,
LinkedIn, YouTube and Instagram.
(VRTX-WEB)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230425005180/en/
Vertex Pharmaceuticals Incorporated Investor Relations:
Susie Lisa, CFA, 617-341-6108 Manisha Pai, 617-961-1899 Miroslava
Minkova, 617-341-6135
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Oct 2023 to Nov 2023
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Nov 2022 to Nov 2023